Lexaria Insider Christopher Bunka Returns 100,000 Shares to Treasury in Zero‑Price Gift, Raising Eyes on Future Buyback Plans
Lexaria Bioscience insider Christopher Bunka returns 100,000 shares to treasury for a zero‑price gift, sparking speculation on future buybacks, share‑price stability, and long‑term investor confidence.
3 minutes to read